Innovex International Inc
For the period ended Dec 31, 2024. Filed Mar 3, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 3, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
SIGNAT URES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized on March 3, 2025.
| INNOVEX INTERNATIONAL, INC. | |
| By: | /s/ Adam Anderson |
| Adam Anderson | |
| Chief Executive Officer |
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.
| Name | Title | Date |
|---|---|---|
| /s/ Adam Anderson | Chief Executive Officer and Director (Principal Executive Officer) | March 3, 2025 |
| Adam Anderson | ||
| /s/ Kendal Reed | Chief Financial Officer (Principal Financial and Accounting Officer) | March 3, 2025 |
| Kendal Reed | ||
| /s/ John Lovoi | Director | March 3, 2025 |
| John Lovoi | ||
| /s/ Terence Jupp | Director | March 3, 2025 |
| Terence Jupp | ||
| /s/ Carri Lockhart | Director | March 3, 2025 |
| Carri Lockhart | ||
| /s/ Jason Turowsky | Director | March 3, 2025 |
| Jason Turowsky | ||
| /s/ Angie Sedita | Director | March 3, 2025 |
| Angie Sedita | ||
| /s/ Bonnie S. Black | Director | March 3, 2025 |
| Bonnie S. Black | ||
| /s/ Benjamin M. Fink | Director | March 3, 2025 |
| Benjamin M. Fink | ||
Index to Consolidated Financial Statements
| Page | |
| Report of Independent Registered Public Accounting Firm (PCAOB ID Number 238) | F-2 |
|---|---|
| Report of Independent Registered Public Accounting Firm (PCAOB ID Number 248) | F-5 |
| Consolidated Balance Sheets | F-6 |
| Consolidated Statements of Operations and Comprehensive Income | F-7 |
| Consolidated Statements of Changes in Stockholders’ Equity | F-8 |
| Consolidated Statements of Cash Flows | F-9 |
| Notes to Consolidated Financial Statements | F-10 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.